These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 12637467)

  • 21. Do tumours located in the left lower lobe have worse outcomes in lymph node-positive non-small cell lung cancer than tumours in other lobes?
    Kudo Y; Saji H; Shimada Y; Nomura M; Usuda J; Kajiwara N; Ohira T; Ikeda N
    Eur J Cardiothorac Surg; 2012 Sep; 42(3):414-9. PubMed ID: 22398463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Omission of Intrapulmonary Lymph Node Retrieval on Outcome Evaluation of Lung Cancer Patients Without Lymph Node Metastasis: A Propensity Score Matching Analysis.
    Wang X; Yan S; Lv C; Wang Y; Wang J; Li S; Zhang L; Yang Y; Wu N
    Clin Lung Cancer; 2017 Nov; 18(6):e411-e416. PubMed ID: 28576593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Appropriate extent of lymph node dissection for clinical I a stage non-small cell lung cancer].
    Pan TC; Zheng Z; Li J; Chen T; Liu LG; Wei X
    Ai Zheng; 2007 Mar; 26(3):303-6. PubMed ID: 17355796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Impact of different mediastinal lymphadenectomy on clinical-stage IA non-small cell lung cancer].
    Ma K; Wang TY; He BL; Chang D; Gong M
    Zhonghua Wai Ke Za Zhi; 2008 May; 46(9):670-3. PubMed ID: 18956719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival analysis of 220 patients with completely resected stage-II non-small cell lung cancer.
    Dai Y; Su XD; Long H; Lin P; Fu JH; Zhang LJ; Wang X; Wen ZS; Zhu ZH; Zhang X; Rong TH
    Chin J Cancer; 2010 May; 29(5):538-44. PubMed ID: 20426905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of pN2 sub-classifications in patients with pathological stage IIIA N2 non-small cell lung cancer.
    Nakagiri T; Sawabata N; Funaki S; Inoue M; Kadota Y; Shintani Y; Okumura M
    Interact Cardiovasc Thorac Surg; 2011 May; 12(5):733-8. PubMed ID: 21297135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postoperative survival and the number of lymph nodes sampled during resection of node-negative non-small cell lung cancer.
    Ludwig MS; Goodman M; Miller DL; Johnstone PA
    Chest; 2005 Sep; 128(3):1545-50. PubMed ID: 16162756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Video-assisted vs open mediastinal lymphadenectomy for Stage I non-small-cell lung cancer: results of a prospective randomized trial.
    Palade E; Passlick B; Osei-Agyemang T; Günter J; Wiesemann S
    Eur J Cardiothorac Surg; 2013 Aug; 44(2):244-9; discussion 249. PubMed ID: 23295451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Impact of the number of resected and involved lymph nodes on the outcome in patients with stage II non-small cell lung cancer].
    Dai Y; Long H; Lin P; Fu JH; Zhang LJ; Zhu ZH; Zhang X; Rong TH; Su XD
    Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):436-40. PubMed ID: 20819485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Time to refine N2 staging? cN2α and cN2β based on local regional involvement provide a more accurate prognosis in surgically treated IIIA non-small-cell lung cancer than N2 alone or the number of node stations involved.
    Matsunaga T; Suzuki K; Takamochi K; Oh S
    Eur J Cardiothorac Surg; 2014 Jul; 46(1):86-91. PubMed ID: 24321998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of the number of lymph nodes examined on the survival of patients with stage I non-small cell lung cancer who undergo sublobar resection.
    Yendamuri S; Dhillon SS; Groman A; Dy G; Dexter E; Picone A; Nwogu C; Demmy T; Hennon M
    J Thorac Cardiovasc Surg; 2018 Jul; 156(1):394-402. PubMed ID: 29709364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radical systematic mediastinal lymphadenectomy versus mediastinal lymph node sampling in patients with clinical stage IA and pathological stage T1 non-small cell lung cancer.
    Ma K; Chang D; He B; Gong M; Tian F; Hu X; Ji Z; Wang T
    J Cancer Res Clin Oncol; 2008 Dec; 134(12):1289-95. PubMed ID: 18504610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic implication of metastasis limited to segmental (level 13) and/or subsegmental (level 14) lymph nodes in patients with surgically resected nonsmall cell lung carcinoma and pathologic N1 lymph node status.
    Maeshima AM; Tsuta K; Asamura H; Tsuda H
    Cancer; 2012 Sep; 118(18):4512-8. PubMed ID: 22282325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of predictive factors for postoperative survival for non small cell lung carcinoma patients with unexpected mediastinal lymph nodes metastasis.
    Wang S; Zhou W; Zhang H; Zhao M; Chen X
    Thorac Cardiovasc Surg; 2014 Mar; 62(2):126-32. PubMed ID: 23585223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequency and prognostic significance of preoperatively detected enlarged regional lymph nodes in patients with pathological stage I non-small cell lung cancer following resection.
    Hoang JK; Patz E; Giroux D; Goldstraw P
    J Thorac Oncol; 2007 Dec; 2(12):1103-6. PubMed ID: 18090582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Time trend of mediastinal lymph node dissection in stage IA non-small cell lung cancer patient who undergo lobectomy: a retrospective study of surveillance, epidemiology, and end results (SEER) database.
    Pan L; Mo R; Zhu L; Yu W; Lv W; Hu J
    J Cardiothorac Surg; 2020 Aug; 15(1):207. PubMed ID: 32738925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mediastinal nodal involvement in patients with clinical stage I non-small-cell lung cancer: possibility of rational lymph node dissection.
    Haruki T; Aokage K; Miyoshi T; Hishida T; Ishii G; Yoshida J; Tsuboi M; Nakamura H; Nagai K
    J Thorac Oncol; 2015 Jun; 10(6):930-6. PubMed ID: 26001143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of Pathologic Nodal Staging Quality With Survival Among Patients With Non-Small Cell Lung Cancer After Resection With Curative Intent.
    Smeltzer MP; Faris NR; Ray MA; Osarogiagbon RU
    JAMA Oncol; 2018 Jan; 4(1):80-87. PubMed ID: 28973110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgical treatment of non-small cell lung cancer: mediastinal lymph node dissection.
    Meacci E; Margaritora S; Cesario A; Porziella V; Kawamukai K; Piraino A; Vita ML; Tessitore A; Cusumano G; Granone P
    Rays; 2004; 29(4):423-9. PubMed ID: 15852730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In patients undergoing lung resection for non-small cell lung cancer, is lymph node dissection or sampling superior?
    Hughes MJ; Chowdhry MF; Woolley SM; Walker WS
    Interact Cardiovasc Thorac Surg; 2011 Sep; 13(3):311-5. PubMed ID: 21606053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.